Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer (Q39710672)

14 September 2017

Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer (English)

1 reference

14 September 2017

1 reference

1 reference

Sokbom Kang

1

1 reference

14 September 2017

Seung Myung Dong

series ordinal

2

1 reference

14 September 2017

Noh-Hyun Park

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

24 April 2010

1 reference

14 September 2017

1 reference

14 September 2017

118

1 reference

14 September 2017

1

1 reference

14 September 2017

58-63

1 reference

The history of cancer epigenetics

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

CpG island methylator phenotype in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

The fundamental role of epigenetic events in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

DNA methylation patterns and epigenetic memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

A genomic scanning method for higher organisms using restriction sites as landmarks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Cloning the differences between two complex genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Genomic fingerprinting using arbitrarily primed PCR and a matrix of pairwise combinations of primers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Epigenetic silencing of novel tumor suppressors in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Estimating the world cancer burden: Globocan 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

The 14-3-3 cancer connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Epigenetic inactivation of Betaig-h3 gene in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Three autosomal dominant corneal dystrophies map to chromosome 5q

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Covalent and non-covalent interactions of betaig-h3 with collagen VI. Beta ig-h3 is covalently attached to the amino-terminal region of collagen VI in tissue microfibrils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Promoter hypermethylation profile of ovarian epithelial neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

FANCF methylation contributes to chemoselectivity in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Overexpression of Betaig-h3 gene downregulates integrin alpha5beta1 and suppresses tumorigenicity in radiation-induced tumorigenic human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Downregulation of Betaig-h3 gene is causally linked to tumorigenic phenotype in asbestos treated immortalized human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

Keratoepithelin suppresses the progression of experimental human neuroblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.025

10.1016/J.YGYNO.2010.03.025

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference